Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control
Hariparsad, Niresh, Ramsden, Diane, Palamanda, Jairam, Dekeyser, Joshua G, Fahmi, Odette A, Kenny, Jane R, Einolf, Heidi, Mohutsky, Michael, Pardon, Magalie, Siu, Y Amy, Chen, Liangfu, Sinz, Michael, Jones, Barry, Walsky, Robert, Dallas, Shannon, Balani, Suresh K, Zhang, George, Buckley, David, Tweedie, Donald
Published in Drug metabolism and disposition (01.10.2017)
Published in Drug metabolism and disposition (01.10.2017)
Get full text
Journal Article
Prediction of CYP Down Regulation after Tusamitamab Ravtansine Administration (a DM4‐Conjugate), Based on an In Vitro–In Vivo Extrapolation Approach
Pouzin, Clemence, Teutonico, Donato, Fagniez, Nathalie, Ziti‐Ljajic, Samira, Perreard‐Dumaine, Anne, Pardon, Magalie, Klieber, Sylvie, Nguyen, Laurent
Published in Clinical pharmacology and therapeutics (01.02.2024)
Published in Clinical pharmacology and therapeutics (01.02.2024)
Get full text
Journal Article
Effect of deuteration on metabolism and clearance of Nerispirdine (HP184) and AVE5638
Schofield, Joseph, Derdau, Volker, Atzrodt, Jens, Zane, Patricia, Guo, Zuyu, van Horn, Robert, Czepczor, Valérie, Stoltz, Axelle, Pardon, Magalie
Published in Bioorganic & medicinal chemistry (01.07.2015)
Published in Bioorganic & medicinal chemistry (01.07.2015)
Get full text
Journal Article